Daiichi Sankyo Company, Limited (DSKYF)

USD 23.0

(9.0%)

Inventory Summary of Daiichi Sankyo Company, Limited

  • Daiichi Sankyo Company, Limited's latest annual inventory in 2024 was 438.11 Billion JPY , up 45.26% from previous year.
  • Daiichi Sankyo Company, Limited's latest quarterly inventory in 2024 FY was 438.11 Billion JPY , up 45.26% from previous quarter.
  • Daiichi Sankyo Company, Limited reported annual inventory of 301.6 Billion JPY in 2023, up 38.41% from previous year.
  • Daiichi Sankyo Company, Limited reported annual inventory of 217.91 Billion JPY in 2022, up 8.49% from previous year.
  • Daiichi Sankyo Company, Limited reported quarterly inventory of 438.11 Billion JPY for 2024 FY, up 45.26% from previous quarter.
  • Daiichi Sankyo Company, Limited reported quarterly inventory of 377.63 Billion JPY for 2024 Q2, up 11.31% from previous quarter.

Annual Inventory Chart of Daiichi Sankyo Company, Limited (2024 - 2000)

Historical Annual Inventory of Daiichi Sankyo Company, Limited (2024 - 2000)

Year Inventory Inventory Growth
2024 438.11 Billion JPY 45.26%
2023 301.6 Billion JPY 38.41%
2022 217.91 Billion JPY 8.49%
2021 200.86 Billion JPY 15.86%
2020 173.36 Billion JPY -1.54%
2019 176.06 Billion JPY 2.02%
2018 172.58 Billion JPY 12.7%
2017 153.13 Billion JPY 6.14%
2016 144.27 Billion JPY -3.88%
2015 150.09 Billion JPY -20.76%
2014 189.4 Billion JPY 8.96%
2013 173.82 Billion JPY 2.61%
2012 169.4 Billion JPY 18.64%
2011 142.79 Billion JPY -0.3%
2010 143.22 Billion JPY 2.69%
2009 139.47 Billion JPY 42.09%
2008 98.15 Billion JPY -8.91%
2007 107.75 Billion JPY -11.45%
2006 121.69 Billion JPY 35.25%
2005 89.97 Billion JPY 0.04%
2004 89.94 Billion JPY 4.02%
2003 86.46 Billion JPY 0.0%
2002 - JPY 0.0%
2001 - JPY 0.0%
2000 - JPY 0.0%

Peer Inventory Comparison of Daiichi Sankyo Company, Limited

Name Inventory Inventory Difference
AstraZeneca PLC 5.41 Billion USD -7988.689%
Bristol-Myers Squibb Company PFD CONV 2 2.66 Billion USD -16357.964%
CSPC Pharmaceutical Group Limited 442.43 Million USD -98923.475%
Clarus Therapeutics Holdings, Inc. 14.21 Million USD -3082149.894%
Novartis AG 5.91 Billion USD -7309.285%
PT Kalbe Farma Tbk. 451.27 Million USD -96981.881%